European Bond Research - July 29, 2019

Posted by Corey Mahoney on Aug 1, 2019 3:01:53 PM
FRENCH PHARMACEUTICAL GIANT SANOFI RALLIED ON MONDAY following revised full-year earnings guidance suggesting 5 percent growth, the stock advanced 2.31 percent. Sanofi bonds also traded notably higher in particular, Sanofi (EUR) 1.25% 3/21/2034. The growth was driven by the launch of a new brand Dupixent, in addition, “Our increased focus in R&D delivered important results with several positive data read-outs and the achievement of regulatory milestones.” FTSE 100 +1.87%, German DAX +0.06%, CAC 40 -0.06%, STOXX Europe 600 +0.18%.  The 10-year Gilt lost 3.6 basis points. 

unnamed - 2019-07-08T161732.486

EUROPEAN COMMISSION OFFICIALS ANNOUNCED BRITAIN will not have immediate access to European financial markets after Brexit even if regulations are identical. Per the commission, “It should be noted that equivalence empowerments do not confer a right on third countries ... to receive an equivalence determination, even if those third countries are able to demonstrate that their framework fulfills the relevant criteria.” The impact on UK financial markets and financial services will be extreme without access to the European Markets, especially within the insurance industry. ADI (Advantage Data Inc.).  Extensive corporate-bond index data showed a net daily yield increment for high-grade versus high-yield constituents. High-grade bonds edged out high-yield debt as of 3 PM, London time.  Among European high-grade bonds showing a concurrence of top price gains at appreciable volumes traded,   GlaxoSmithKline Capital Inc. (USD) 2.85% 5/8/2022  made some analysts' 'Conviction Buy' lists. (See the chart for GlaxoSmithKline Capital Inc.  below). Corey Mahoney (

Credit-Default Swap Market

LATEST NEWS: Top moves, sovereign tighteners (5Y): Korea 28 bp and China 39 bp. Sovereign wideners (5Y): Indonesia 78 bp and Panama 52 bp.

unnamed - 2019-08-01T150038.047

New Issuance

New Issues New Issues [Continued]

(None Current 07/29/2019)



ADI Indexes

unnamed - 2019-07-18T115657.384

iShares Core EUR UCITS iShares Euro High Yield UCITS
NAV as of 07/29/2019, 135.13 NAV as of 07/29/2019, 105.60
Daily NAV Change (%) +0.11% Daily NAV Change (%) -0.09%

The euro-zone economy shows signs of positive momentum, although conditions are expected to deteriorate hindered by the termination of quantitative easing, weakening credit rating quality, and uncertainty regarding the outcome of Brexit. Closely watched indicators and rates:
  • Eurostat's unemployment ratecurrently 7.5% (seasonally adjusted, May 2019)
  • Eurostat's quarterly GDP: 0.4% (2019 Q1)
  • 6-month Euribor: current value -0.362%, as of 07/26/2019

Copyright 2019 Advantage Data Inc. All Rights Reserved.

Information in this document should not be regarded as an offer to sell or solicitation of an offer to buy bonds or any financial instruments referred to herein. All information provided in this document is believed to be accurate. However, Advantage Data and its sources make no warranties, either express or implied, as to any matter whatsoever, including but not limited to warranties of merchantability or fitness for a particular purpose. Opinions in this document are subject to change without notice. Electronic redistribution, photocopying and any other electronic or mechanical reproduction is strictly prohibited without prior written permission from Advantage Data Inc.

Topics: Analytics, bonds, junk bonds, bond market, corporate bonds, market analytics, New Issues, News, research, EU, market update, European

Are you using AdvantageData?

AdvantageData is your fixed income solution for pricing, analytics, reports, and insight on approximately:

  • 500,000+ U.S. and international corporate bonds
  • Over 6,200+ CDS reference entities
  • Over 22,000+ syndicated loans
  • Over 100 equity markets worldwide
  • One platform 16 products and services from debt to CDS to loans to mid-market
  • Used by top buy and sell-side firms worldwide

Subscribe to Email Updates

Recent Posts